Drugplain

Humalog Junior KwikPen 100 [iU]/mL

Insulin lispro · INJECTION, SOLUTION · Eli Lilly and Company

No Recall HistoryCurrently in Shortage
Plain English

Humalog Junior KwikPen is a injection, solution containing insulin lispro at 100 [iU]/mL, taken subcutaneous. Manufactured by Eli Lilly and Company.

Key Facts

Brand Name
Humalog Junior KwikPen
Generic Name
Insulin lispro
NDC Code (Product)
0002-7714
Manufacturer
Eli Lilly and Company
Strength
100 [iU]/mL
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Marketing Status
Application #
BLA020563
Drug Class
Insulin Analog [EPC]
Marketing Start
06/06/2017

Recall History

No Recall History

Frequently Asked Questions

What is Humalog Junior KwikPen used for?

Humalog Junior KwikPen contains Insulin lispro. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.

Is Humalog Junior KwikPen a controlled substance?

Humalog Junior KwikPen is not classified as a controlled substance by the DEA.

What is the generic name for Humalog Junior KwikPen?

The generic name for Humalog Junior KwikPen is Insulin lispro. There are 11 other brand versions of Insulin lispro.

What is the NDC code for Humalog Junior KwikPen 100 [iU]/mL?

The NDC (National Drug Code) for Humalog Junior KwikPen 100 [iU]/mL is 0002-7714, listed by Eli Lilly and Company.